RLAY vs SDGR
RLAY 与 SDGR 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | RLAYRelay Therapeutics, Inc. | SDGRSchrodinger, Inc. |
|---|---|---|
| 市值 | $3.52B | — |
| 市销率 | 228.0x | — |
| 营收 | — | $254.91M(TTM) |
| 营收同比增长 | 53.4% | 23.3% |
| 净利润 | — | -$103.48M(TTM) |
| 净利同比增长 | 18.1% | 44.8% |
| 每股收益(稀释) | — | $-1.40(TTM) |
| 息税前利润率 | -1971.6% | -65.2% |
| 净资产收益率 | -43.1% | -32.9% |
| 一年总回报 | +405.5% | -27.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:RLAY vs SDGR
| 指标 | RLAY | SDGR |
|---|---|---|
| 期末价值 | $5.2K | $1.9K |
| 总回报 | -47.6% | -80.9% |
| 年化收益 (CAGR) | -10.2% | -24.0% |
| 波动率 | 77.4% | 64.2% |
| 夏普比率 | 0.19 | -0.17 |
| 索提诺比率 | 0.29 | -0.25 |
| 最大回撤 | -96.8% | -90.2% |
基于 1516 个共同交易日,2020-07-16 → 2026-07-29 · 无风险利率 3.9%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)